Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,253
Closed -$58K 2402
2022
Q2
$58K Buy
+3,253
New +$76.4K ﹤0.01% 1341
2022
Q1
Sell
-2,067
Closed -$57K 2300
2021
Q4
$57K Buy
2,067
+1,592
+335% +$45K ﹤0.01% 1309
2021
Q3
$13K Sell
475
-605
-56% -$16.2K ﹤0.01% 1768
2021
Q2
$30K Buy
1,080
+107
+11% +$2.85K ﹤0.01% 1573
2021
Q1
$21K Buy
+973
New +$19.9K ﹤0.01% 1465
2020
Q4
Sell
-2,364
Closed -$37K 2037
2020
Q3
$37K Buy
+2,364
New +$36.5K ﹤0.01% 745
2019
Q3
Sell
-377
Closed -$8K 1332
2019
Q2
$8K Buy
+377
New +$8.75K ﹤0.01% 874
2017
Q1
Sell
-578
Closed -$14K 969
2016
Q4
$14K Buy
+578
New +$12.2K 0.01% 602

Other funds holding TBI

Point72 Hong Kong's TBI Position: Q3 2022 in Review

Point72 Hong Kong sold out of Trueblue (TBI) in Q3 2022, closing a stake of 3,253 shares — an estimated $58K sold.

Point72 Hong Kong first reported a position in TBI in Q4 2016 and held it in 8 quarters. The position peaked at $58K in Q2 2022. 172 funds tracked by Wall St. Rank hold TBI as of Q3 2022.

  • Point72 Hong Kong reported no remaining Trueblue position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 3,253 Trueblue shares in Q3 2022, an estimated $58K.
  • Point72 Hong Kong first reported a position in Trueblue in Q4 2016 and held it in 8 quarters.
  • Point72 Hong Kong's Trueblue position peaked at $58K in Q2 2022.
  • 172 funds tracked by Wall St. Rank held Trueblue as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.